Navigation Links
ViroPharma Launches 'HAE and Me,' A New Online Community to Unite People Living With Hereditary Angioedema
Date:3/21/2011

ritten profiles of people with HAE and physicians
  • Tips and advice from people with HAE and physicians
  • Quarterly physician spotlights
  • Monthly polls
  • Answers to frequently asked questions about HAE
  • Upcoming events

  • "Gen HAE," which was developed with input from teens and young adults living with HAE, focuses specifically on the important issues young people growing up with chronic conditions like HAE may face.  Unique to "Gen HAE," visitors can also submit questions to Dr. Miriam Kaufman, a pediatrician who has worked for 27 years with young people who have chronic conditions.  

    Information on "HAE and Me" will be regularly updated to include new information and interactive elements, potentially including an interactive map to visually link HAE patients, and a calendar of relevant events around the country.  "HAE and Me" will also expand to include targeted content for other sub-communities of people affected by HAE, such as parents or caregivers.

    About Hereditary Angioedema

    HAE is a rare, severely debilitating, life-threatening genetic disorder caused by a deficiency of C1 inhibitor, a human plasma protein. This condition is the result of a defect in the gene controlling the synthesis of C1 inhibitor. C1 inhibitor maintains the natural regulation of the contact, complement, and fibrinolytic systems, that when left unregulated, can initiate or perpetuate an attack by consuming the already low levels of endogenous C1 inhibitor in HAE patients. Patients with C1 inhibitor deficiency experience recurrent, unpredictable, debilitating, and potentially life threatening attacks of inflammation affecting the larynx, abdomen, face, extremities and urogenital tract. Patients with HAE experience approximately 20 to 100 days of incapacitation per year. There are estimated to be at least 6,500 people with HAE in the United States.

    For more information o
    '/>"/>

    SOURCE ViroPharma Incorporated
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor [Human]) in European Union
    2. ViroPharma Announces Securities Repurchase Program
    3. ViroPharma to Participate in Two March Healthcare Conferences
    4. ViroPharma to Release 2010 Fourth Quarter and Full Year Financial Results on February 24, 2011
    5. ViroPharma to Participate in Several Upcoming Healthcare Investor Conferences
    6. ViroPharma Receives Complete Response Letter for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Supplement
    7. ViroPharma to Release 2010 Third Quarter Financial Results on October 27, 2010
    8. ViroPharma to Present at the Jefferies 2010 Global Healthcare Conference
    9. ViroPharma Announces Presentation of Data from Non-Toxigenic Clostridium difficile (VP20621) Phase 1 Study
    10. ViroPharma To Participate in Two September Healthcare Investor Conferences
    11. ViroPharma Announces Publication of Cinryze™ (C1 Esterase Inhibitor [Human]) Phase 3 Trial Results in Hereditary Angioedema (HAE) in the New England Journal of Medicine
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/28/2014)...  Luminex Corporation (NASDAQ: LMNX ) today ... 30, 2014. Financial and operating highlights include the following: ... million, a 2 percent increase over the second quarter ... $8.3 million, a 9 percent increase over the second ... 268 multiplexing analyzers, which included 148 LX systems, 96 ...
    (Date:7/28/2014)... 2014 /PRNewswire-iReach/ -- June 28 th , 2014 – Oncolab, ... the AMAS cancer test, is making its AACC debut (booth ... test, which is a serum-based in vitro immunoassay, has been ... significant tool in the fight against cancer recurrence. ... estimated 17 million cancer survivors in the US alone, the ...
    (Date:7/28/2014)...  Air Products (NYSE: APD ) understands ... vital to any healthcare facility. This understanding has driven ... the efficiency of its oxygen supply systems, but also ... systems for emergency oxygen supply and high ... the 51 st ASHE Annual Conference & ...
    Breaking Medicine Technology:Luminex Corporation Reports Second Quarter 2014 results 2Luminex Corporation Reports Second Quarter 2014 results 3Luminex Corporation Reports Second Quarter 2014 results 4Luminex Corporation Reports Second Quarter 2014 results 5Luminex Corporation Reports Second Quarter 2014 results 6Luminex Corporation Reports Second Quarter 2014 results 7Luminex Corporation Reports Second Quarter 2014 results 8Luminex Corporation Reports Second Quarter 2014 results 9Luminex Corporation Reports Second Quarter 2014 results 10Luminex Corporation Reports Second Quarter 2014 results 11Luminex Corporation Reports Second Quarter 2014 results 12Luminex Corporation Reports Second Quarter 2014 results 13Luminex Corporation Reports Second Quarter 2014 results 14Luminex Corporation Reports Second Quarter 2014 results 15Luminex Corporation Reports Second Quarter 2014 results 16Luminex Corporation Reports Second Quarter 2014 results 17Oncolab, Inc. Exhibits Pioneering AMAS Cancer Test at AACC 2Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 2Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 3
    ... BOSTON, Feb. 16, 2011 MedAptus®, the market ... New England Baptist Hospital (NEBH) has selected the ... inpatient medicine providers. The NEBH hospitalist team, comprised ... MedAptus, Inpatient Edition via the web as well ...
    ... Feb. 15, 2011 Warner Chilcott plc (Nasdaq: WCRX ... full year 2010 financial results prior to the market opening on ... a press release, the Company will host a conference call for ... (Eastern Time) to review the results. To participate in the call, ...
    Cached Medicine Technology:Hospitalists at New England Baptist Hospital Choose MedAptus 2
    (Date:7/28/2014)... 2014 Ticket Down is reliable ... in Dallas, TX at the Cotton Bowl. The 2014 ... USA and it is an eight team tourney. The ... including teams from La Liga, Serie A, English Premier League, ... it out on the pitch include: Manchester United, Manchester ...
    (Date:7/28/2014)... 2014 Cape Regional Medical Center, ... technology solution in an effort to streamline ... collaboration with their New Jersey health information exchange ... located in New Jersey, serves the local population ... variety of inpatient and outpatient services. With a ...
    (Date:7/28/2014)... (HealthDay News) -- British researchers report that an alternative ... around. In their experiments, the scientists found that ... one person to the other than what is known ... exchange might suffice as a cultural substitute for the ... in the August issue of the American Journal ...
    (Date:7/28/2014)... SIMpalm helped its client to launch ... on iTunes for download . Experience a new way ... you to listen and cook along with expert real-time audio ... out the ingredients and equipment, press play, and follow the ... ahead of time, just relax and cook along with us. ...
    (Date:7/28/2014)... LA JOLLAWhen you,re expecting somethinglike the meal you,ve ... interest, unique electrical rhythms sweep through your brain. ... and they reflect a symphony of cellsboth excitatory ... their role has been debated, gamma waves have ... in the patterns have been tied to schizophrenia, ...
    Breaking Medicine News(10 mins):Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Cuts Ticket Prices for AS Roma vs. Real Madrid International Champions Cup Tickets 2Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Cuts Ticket Prices for AS Roma vs. Real Madrid International Champions Cup Tickets 3Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 2Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 3Health News:'Fist Bump' May Beat Handshake for Cleanliness 2Health News:'Fist Bump' May Beat Handshake for Cleanliness 3Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 2Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 3Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 4Health News:Memory relies on astrocytes, the brain's lesser known cells 2Health News:Memory relies on astrocytes, the brain's lesser known cells 3
    ... ... warning concerning the osteoporosis drug Fosamax as The Sanders Firm prepares for the first ... ... States Food and Drug Administration, via its website at FDA.gov , has issued ...
    ... the California Dental Association (CDA) Foundation has released new guidelines designed to emphasize the safety of dental treatment during pregnancy and ensure women the services they need. , ... , ... ... ...
    ... ... same HCG diet that doctors are charging thousands of dollars for. , ... (PRWEB) March 15, 2010 -- YourHCG.com ... plans. YourHCG.com has helped over 50,000 people lose weight for about 10% of what the ...
    ... MISSISSAUGA, ON , March 15 /PRNewswire-FirstCall/ - Nuvo ... on the research and development of drug products that are ... transdermal drug delivery technologies, and on the development of its ... enrolled the first patient in its European Phase 2 clinical ...
    ... eight times more likely to die, study finds , MONDAY, March ... hip are five to eight times more likely to die in ... Belgian researchers has found. , And, while the death rate after ... the break, it never returns to the death rate seen in ...
    ... link between obesity and disease has been well documented. There,s ... as they,ve shown in the United States at least 90,000 ... of Alberta researcher Richard Lamb is on his way to ... the scientific process works. Lamb is studying a cell ...
    Cached Medicine News:Health News:The Sanders Firm is Assigned the First Fosamax Trial 2Health News:The Sanders Firm is Assigned the First Fosamax Trial 3Health News:California Dental Association Foundation Releases New Oral Health Guidelines for Pregnant Women 2Health News:California Dental Association Foundation Releases New Oral Health Guidelines for Pregnant Women 3Health News:California Dental Association Foundation Releases New Oral Health Guidelines for Pregnant Women 4Health News:YourHCG.com Changes the Way People Lose Weight by Offering an Affordable HCG Diet Plan 2Health News:Nuvo Research enrolls first patient in Phase 2 WF10 allergic rhinitis trial 2Health News:Nuvo Research enrolls first patient in Phase 2 WF10 allergic rhinitis trial 3Health News:Nuvo Research enrolls first patient in Phase 2 WF10 allergic rhinitis trial 4Health News:Nuvo Research enrolls first patient in Phase 2 WF10 allergic rhinitis trial 5Health News:Risk of Death Persists After a Hip Fracture 2Health News:Risk of Death Persists After a Hip Fracture 3
    ... Self-Cath family of 100% ... a variety of options ... Each catheter is made ... PVC and has smooth ...
    Used for intermittent catheterization of a male or female patient to provide drainage of urine from the bladder. Supplied sterile in peel-open packages. Intended for one-time use....
    An enzyme-linked immuno-sorbent assay for the detectionand quantitation of anti-tissue Transglutaminase in serum of patients with Celiac Disease and Dermatitis Herpetiformis....
    ... Scoliosis Brace™ for neuromuscular scoliosis ... lightweight, soft, and easy to ... comfort. The Soft Boston ... non-cracking orthopedic grade copolymer and ...
    Medicine Products: